BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24634143)

  • 1. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.
    Joeng KS; Lee YC; Lim J; Chen Y; Jiang MM; Munivez E; Ambrose C; Lee BH
    J Clin Invest; 2017 Jun; 127(7):2678-2688. PubMed ID: 28628032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of WNT1 mutant variant (WNT1
    Zhang B; Li R; Wang W; Zhou X; Luo B; Zhu Z; Zhang X; Ding A
    Ann Hum Genet; 2020 Nov; 84(6):447-455. PubMed ID: 32757296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation.
    Wang F; Tarkkonen K; Nieminen-Pihala V; Nagano K; Majidi RA; Puolakkainen T; Rummukainen P; Lehto J; Roivainen A; Zhang FP; Mäkitie O; Baron R; Kiviranta R
    J Bone Miner Res; 2019 Jun; 34(6):1129-1142. PubMed ID: 30690791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel missense loss-of-function mutations of WNT1 in an autosomal recessive Osteogenesis imperfecta patient.
    Won JY; Jang WY; Lee HR; Park SY; Kim WY; Park JH; Kim Y; Cho TJ
    Eur J Med Genet; 2017 Aug; 60(8):411-415. PubMed ID: 28528193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ptosis as a unique hallmark for autosomal recessive WNT1-associated osteogenesis imperfecta.
    Nampoothiri S; Guillemyn B; Elcioglu N; Jagadeesh S; Yesodharan D; Suresh B; Turan S; Symoens S; Malfait F
    Am J Med Genet A; 2019 Jun; 179(6):908-914. PubMed ID: 30896082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations.
    Liu Y; Song L; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Song Y; Xing X; Asan ; Li M
    Clin Chim Acta; 2016 Oct; 461():172-80. PubMed ID: 27450065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in WNT1 are a cause of osteogenesis imperfecta.
    Fahiminiya S; Majewski J; Mort J; Moffatt P; Glorieux FH; Rauch F
    J Med Genet; 2013 May; 50(5):345-8. PubMed ID: 23434763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutation G324C in WNT1 mapped in a large Pakistani family with severe recessively inherited Osteogenesis Imperfecta.
    Kausar M; Siddiqi S; Yaqoob M; Mansoor S; Makitie O; Mir A; Khor CC; Foo JN; Anees M
    J Biomed Sci; 2018 Nov; 25(1):82. PubMed ID: 30447692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.
    Pyott SM; Tran TT; Leistritz DF; Pepin MG; Mendelsohn NJ; Temme RT; Fernandez BA; Elsayed SM; Elsobky E; Verma I; Nair S; Turner EH; Smith JD; Jarvik GP; Byers PH
    Am J Hum Genet; 2013 Apr; 92(4):590-7. PubMed ID: 23499310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand.
    Luther J; Yorgan TA; Rolvien T; Ulsamer L; Koehne T; Liao N; Keller D; Vollersen N; Teufel S; Neven M; Peters S; Schweizer M; Trumpp A; Rosigkeit S; Bockamp E; Mundlos S; Kornak U; Oheim R; Amling M; Schinke T; David JP
    Sci Transl Med; 2018 Nov; 10(466):. PubMed ID: 30404864
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel mutation in a family with WNT1-related osteoporosis.
    Panigrahi I; Didel S; Kirpal H; Bellampalli R; Miyanath S; Mullapudi N; Rao S
    Eur J Med Genet; 2018 Jul; 61(7):369-371. PubMed ID: 29481978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consanguineous-derived homozygous WNT1 mutation results in osteogenesis imperfect with congenital ptosis and exotropia.
    Chen P; Chen J; Yang Z; Lu Y; Shen L; Zhou K; Ye S; Shen B
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1350. PubMed ID: 32529806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
    Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous WNT1 variant causing a variable bone phenotype.
    Alhamdi S; Lee YC; Chowdhury S; Byers PH; Gottschalk M; Taft RJ; Joeng KS; Lee BH; Bird LM
    Am J Med Genet A; 2018 Nov; 176(11):2419-2424. PubMed ID: 30246918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.
    Besio R; Chow CW; Tonelli F; Marini JC; Forlino A
    FEBS J; 2019 Aug; 286(15):3033-3056. PubMed ID: 31220415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
    Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
    Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
    Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
    Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.